Neoplasms

The site conducts extensive research on solid tumors, targeting a broad spectrum of cancers.

  • Advanced breast cancer
  • Metastatic colorectal cancer
  • HER2‑positive gastric cancer
  • High‑grade serous ovarian cancer
  • Metastatic renal cell carcinoma

Trials aim to evaluate novel targeted therapies and immunotherapy regimens to improve survival.

Hemic and Lymphatic Diseases

Investigations focus on hematologic malignancies including leukemia and lymphoma.

  • Chronic lymphocytic leukemia
  • Diffuse large B‑cell lymphoma
  • Multiple myeloma
  • Follicular lymphoma
  • Acute myeloid leukemia

Studies assess the efficacy of new cell‑based immunotherapies and combination regimens.

Respiratory Tract Diseases

Research addresses lung cancers and related thoracic conditions.

  • Non‑small cell lung cancer
  • Small‑cell lung cancer
  • Large‑cell neuroendocrine carcinoma
  • Malignant pleural mesothelioma
  • KRAS‑mutated NSCLC

Goals include testing innovative immuno‑oncology agents and precision‑medicine approaches.

Digestive System Diseases

Clinical work explores gastro‑intestinal malignancies across the digestive tract.

  • Colorectal cancer
  • Gastric adenocarcinoma
  • Pancreatic ductal adenocarcinoma
  • Small bowel adenocarcinoma
  • Hepatocellular carcinoma

Efforts seek to improve treatment sequencing and biomarker‑driven therapies.

Female Urogenital Diseases

Studies concentrate on gynecologic cancers affecting women.

  • Ovarian carcinoma
  • Endometrial carcinoma
  • Cervical cancer
  • Fallopian tube cancer
  • High‑risk HR‑positive/HER2‑negative breast cancer

Trials evaluate new hormone‑targeted and immunotherapeutic options.

Musculoskeletal Diseases

The department investigates bone and soft‑tissue sarcomas.

  • Leiomyosarcoma
  • Osteosarcoma
  • Soft‑tissue sarcoma
  • Metastatic bone disease
  • Sarcoma with novel agents

Research aims to determine the benefit of targeted kinase inhibitors in sarcoma care.

Nutritional and Metabolic Diseases

Projects include metabolic profiling in cancer patients, focusing on nutritional status.

  • Cancer‑associated cachexia
  • Metabolic biomarkers
  • Nutritional support interventions
  • Obesity‑related cancer risk
  • Diabetes impact on treatment

Objectives are to refine supportive care strategies that enhance outcomes.

Skin and Connective Tissue Diseases

Research covers melanoma and cutaneous tumors.

  • Melanoma
  • Merkel cell carcinoma
  • Cutaneous squamous cell carcinoma
  • Dermatologic manifestations of systemic therapy
  • Immunotherapy for skin cancers

Studies aim to validate immune checkpoint inhibitors and combination approaches.